The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
ReproCELL
Yokohama, Japan
A
51-100 Employees
2003
Key takeaway
REPROCELL offers a comprehensive portfolio of products and services that support stem cell research, including a wide range of stem cell reagents and the supply of induced pluripotent stem cells (iPSCs) for research and clinical applications. The company also leverages its expertise in pluripotent and mesenchymal stem cells to develop novel regenerative medicine therapies and is actively conducting clinical trials for related treatments.
Reference
Product
Products: Stem Cell Reagents
Browse a range of Stem Cell Reagents on the REPROCELL website. Request a quote from the iPSC experts for delivery to the USA or Europe.
Kintaro Cells Power International
Tokyo, Japan
A
11-50 Employees
2011
Key takeaway
Kintaro Cells Power focuses on harnessing mesenchymal stem cells (MSCs) to enhance health, beauty, and longevity. Their products are rooted in over 50 years of Russian stem cell research, highlighting the potential of MSCs to rejuvenate and repair damaged tissues in the body.
Reference
Core business
Kintaro Cells Power
Stem Cell & Device Laboratory
Kyoto, Japan
A
1-10 Employees
2014
Key takeaway
The company offers a functional neuron maturation device that enhances the application of microelectrode arrays for measuring neural networks, which is relevant to stem cell research and development.
Reference
Product
PRODUCTS・SERVICES | Stem Cell & Device Laboratory, Inc.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
VC Cell Therapy
Kyōtango, Japan
A
- Employees
2021
Key takeaway
The company is focused on developing high-quality stem cells for clinical use, particularly in relation to retinal health, where abnormalities in retinal pigment epithelium (RPE) cells can lead to degenerative diseases. They are also exploring logistics to provide innovative therapies, including autologous cell therapy, that leverage the patient's own cells for treatment.
Reference
Core business
株式会社VC Cell Therapy
NEWS
ThinkCyte
Tokyo, Japan
A
11-50 Employees
2016
Key takeaway
The company focuses on advancing biology and medicine through innovative therapies and diagnostics, particularly in cell therapy. Their unique Ghost Cytometry technology enables label-free characterization and isolation of stem cells and other cell types by analyzing morphological differences, enhancing the efficiency of the cell therapy manufacturing process.
Reference
Product
Cell Therapy - ThinkCyte
Label-free Monitoring and Isolation of Target Cells Our Solution for Cell Therapy Conventionally, surface markers or stains have been necessary to characterize and isolate target cells in the cell therapy manufacturing process. By applying Ghost Cytometry, we perform label-free characterization and isolation of cells at high throughput by using machine predicted “in-silico” labels. Our technology can classify and isolate cells based on morphological differences and has been used for identifying live and dead cells, activated and resting T cells, and differentiated and undifferentiated stem cells. It has also been used to assess more subtle morphological variations in cells and organelles including cell-cycle phases, glycolytic levels, and apoptotic status. This technology … Continued
Thyas Co. Ltd.
Kyoto, Japan
A
1-10 Employees
2015
Key takeaway
The company, サイアス株式会社, specializes in regenerating T cells from human iPS cells to develop regenerative immunotherapy treatments for cancer and infections. This aligns closely with the query on stem cells, particularly in the context of their application in advanced medical therapies.
Reference
Core business
サイアス株式会社
サイアス株式会社はヒトiPS細胞からT細胞を再生し、がんや感染症に対する再生免疫細胞療法の製剤を提供することを事業目的としています。
Minaris Regenerative Medicine
Tokyo, Japan
A
501-1000 Employees
-
Key takeaway
Minaris Regenerative Medicine is a prominent contract development and manufacturing organization specializing in the production of cell and gene therapy products. With over 20 years of experience, the company emphasizes quality and reliability in its clinical and commercial manufacturing services, aiming to advance cell therapy innovations.
Reference
Service
QP Batch Certification | Minaris Regenerative Medicine
For cell and gene therapy products manufactured outside the European Union, Minaris Regenerative Medicine offers batch release to the EU market by Qualified Persons (QP).
T Cell Nouveau
Tokyo, Japan
A
1-10 Employees
2021
Key takeaway
T Cell Nouveau Inc. is advancing innovative Hybrid CAR T-cell therapy, which represents a significant breakthrough in the treatment of solid tumors, building on the foundation of modern CAR/TCR-T cell therapies.
Reference
Product
Technology | T Cell Nouveau Inc.
CAR-T細胞治療 自己由来CAR-T細胞治療
MiCAN Technologies
Kyoto, Japan
A
1-10 Employees
2016
Key takeaway
MiCAN Technologies, Inc. specializes in producing high precision human blood cells using regenerative medicine technologies, including the development of blood cell-like cells for research. Their innovations significantly enhance the evaluation of drug efficacy and safety, particularly for COVID-19.
Reference
Core business
MiCAN Technologies / マイキャン・テクノロジーズ株式会社
For research on malaria,our newly developed MPV cells will solve the shortage of supply of reticulocyte cells and support researches to eradicate such diseases.
The Japanese Society for Regenerative Medicine
Kobe, Japan
A
5001-10000 Employees
2001
Key takeaway
The Japanese Society for Regenerative Medicine (JSRM) is actively involved in the approval process of regenerative medicine products in Japan and has launched the "REAP" service, which is a data registration system aimed at facilitating unrestricted clinical practice.
Reference
Core business
The Japanese Society for Regenerative Medicine
Orchestrating Wisdom to Innovate, Universalize for the Happiness and Future of All Human Beings.
Technologies which have been searched by others and may be interesting for you:
Japan's stem cell industry is characterized by several vital considerations that potential investors or researchers should keep in mind. The regulatory environment is stringent, with the Pharmaceuticals and Medical Devices Agency (PMDA) overseeing clinical trials and therapies involving stem cells. Understanding these regulations is crucial, as they can significantly impact the pace of development and commercialization. Challenges in this field include ethical concerns surrounding the sourcing of stem cells, particularly from embryonic sources, which can influence public perception and policy. However, Japan offers substantial opportunities, especially in regenerative medicine, due to its aging population and government support for research funding and innovation. The competitive landscape features both established companies and startups, making it essential to identify key players and their unique offerings. Additionally, the global market relevance of Japan's stem cell research is significant, as the country is at the forefront of advancements in this area, including induced pluripotent stem cells (iPSCs). Environmental concerns are also rising, particularly related to the sustainability of sourcing materials used in stem cell research. Overall, a comprehensive understanding of these factors will provide valuable insights for anyone exploring the stem cell industry in Japan.
Some interesting numbers and facts about your company results for Stem Cell
| Country with most fitting companies | Japan |
| Amount of fitting manufacturers | 21 |
| Amount of suitable service providers | 9 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2001 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Stem Cell
What are related technologies to Stem Cell?
Based on our calculations related technologies to Stem Cell are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Stem Cell?
Start-Ups who are working in Stem Cell are T Cell Nouveau
Which industries are mostly working on Stem Cell?
The most represented industries which are working in Stem Cell are Biotechnology, Other, IT, Software and Services, Pharmaceuticals, Medical
How does ensun find these Stem Cell Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
